Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Jullien

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
Annales De Dermatologie Et De Venereologie|June 19, 2019
[Ustekinumab]D Jullien, D Staumont-Salle,
Annales De Dermatologie Et De Venereologie|March 18, 2008
[Genetics of skin barrier impairment in atopic dermatitis]V Audigier, A Shisha, D Jullien
Mechanisms of Development|February 12, 1998
cDNA sequence and expression pattern of the Drosophila melanogaster PAPS synthetase gene: a new salivary gland markerD Jullien, M Crozatier, E Käs
La Revue Du Praticien|February 24, 2001
[Drug-induced skin diseases. Diagnosis]D Jullien, S Grande, M Faure
Annales De Dermatologie Et De Venereologie|June 28, 2011
[Nail psoriasis: a marker of profound inflammation]D Jullien, B Fournié, S Boulinguez
Medical & Biological Engineering & Computing|May 1, 1994
Optimisation of pulse duration for intravaginal electrical stimulation: effect of tissue excitabilityM Malissard, J Souquet, D Jullien
European Journal of Immunology|November 1, 1973
Studies in vascular permeability. II. Comparative extravasation of different immunoglobulin classes in normal guinea pig skinD Jullien-Vitoux, G A Voisin
British Journal of Experimental Pathology|February 1, 1973
Studies on vascular permeability. I. Description and evaluation of methodsD Jullien-Vitoux, G A Voisin, M Nemirovky
The Journal of Investigative Dermatology|November 1, 1992
Keratinocyte migration is partially supported by the cell-binding domain of fibronectin and is RGDS-dependentY Sarret, C Stamm, D Jullien, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 16, 2021
Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2C Lesort, J Kanitakis, L Donzier, et al.
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Annales De Dermatologie Et De Venereologie|June 19, 2019
[Ustekinumab]D Jullien, D Staumont-Salle,
Annales De Dermatologie Et De Venereologie|March 18, 2008
[Genetics of skin barrier impairment in atopic dermatitis]V Audigier, A Shisha, D Jullien
Mechanisms of Development|February 12, 1998
cDNA sequence and expression pattern of the Drosophila melanogaster PAPS synthetase gene: a new salivary gland markerD Jullien, M Crozatier, E Käs
La Revue Du Praticien|February 24, 2001
[Drug-induced skin diseases. Diagnosis]D Jullien, S Grande, M Faure
Annales De Dermatologie Et De Venereologie|June 28, 2011
[Nail psoriasis: a marker of profound inflammation]D Jullien, B Fournié, S Boulinguez
Medical & Biological Engineering & Computing|May 1, 1994
Optimisation of pulse duration for intravaginal electrical stimulation: effect of tissue excitabilityM Malissard, J Souquet, D Jullien
European Journal of Immunology|November 1, 1973
Studies in vascular permeability. II. Comparative extravasation of different immunoglobulin classes in normal guinea pig skinD Jullien-Vitoux, G A Voisin
British Journal of Experimental Pathology|February 1, 1973
Studies on vascular permeability. I. Description and evaluation of methodsD Jullien-Vitoux, G A Voisin, M Nemirovky
The Journal of Investigative Dermatology|November 1, 1992
Keratinocyte migration is partially supported by the cell-binding domain of fibronectin and is RGDS-dependentY Sarret, C Stamm, D Jullien, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 16, 2021
Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2C Lesort, J Kanitakis, L Donzier, et al.
Pageof 16